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SE1HOR THESIS

THE l.JlENOPAUSE

With special reference to endocrine therapy.

Apljil 20, 1933.

Harry A. Jakeman

A discussion of al} phases of the menopause would be practically
imposei ble in a paper of this nature.
profession~

the

Everyone connected with the medical

however, is well acquainted with this syndrome and realizes

import~mce

of its place in the medical curriculum regardless of t:he

particular line of medic ine in which one may be interested.
By way of introduction, I will discuss briefly the menopause as to

etiology I symptomatology, and ccurse, the chief object of this paper being
that of' therapeuti.cs.
Tilt, in 1882, was perhaps the first man to write intelligently and
scientifically upon this subject.

His work was published in book form.

In this publication, he attempted to define the condition as follows: "The

terms 'climacteria' in Latin; 'climacteric disease', 'change of life',
'critical time', 'turn of life', in English; 'temps critique',

'a~e

de

retour', am 'menopause T J in French; and 'aufhoren der weiblichen reinigung'
in German; .are understood to mean a certain period of time, beginning with
those irregularities which precede the last appearance of the menstrual
flow, and ending with the resettlement of health".
Tilt recognized the fact that this phenomenon was, in all probability,
dUG

,,0

ovarian changes and he called attenti'On to the atrophied condition

of the reproduction systeril of Vliomen going througtl this change.

Tilt says,

"While involution is taking place, the 'Ovaries disturb the viscera, with
which they have worked harmoniously for thirty years".

At that time, the

nature of the disturbance was not known but was thought to be similar to
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that made l11an ifest by the coming into power of the ovaries at puberty,
because the s;Ylr,ptOIIJB at both periods of life are very siIr.ilar.
Treatmerrb at this tilne consisted chiefly of sedation and general
oonstitutional measures fair degree of suocess.

baths~

etc.

Bromides were used by Tilt with a

Bleeding was also done

1!f many practitioners at

this time.
Some fifteen years later, Currier

publi~<ed

~'

J..l~S

1)10

rk

OIl

the menopause.

In this "WOrk Currier states, I'For many centuries, the importance of the

menstrua.l function in women has been a recog:n.ized fact among critical
observers.

Its significance has of course, been differently interpreted

by observers in different ages and in different conditions of intellectual
development.

Among the crude, the barbarous, and the superstitious, the

solution of such a problem would not be one vmich would be universally
satisfactory.

Even among higply developed nations, like

th~t

of the

Greeks" the interpretation could not be expected to co nform to the facts
because of imperfect knowledge in physiology and anatomy".
The Egyptians, who investigated sO many matters concerning the
human body, realized that menstruation was an importent funotion.

This is

shown irl the books of Moses, much infonne.tion of which was derived from
Egyptian scurces, and in which a menstruating woman was decle.red ceremonially unclean, coitus 1'II-i th her beirg forbidden.

But Wli1e the

importance of menstruation was quite generally recognized among the
more acute of the ancient observers, it was not so with the menopause.
By some it was passed over as a matter occult and inexplioable, and, in
general, it failed to receive that broad and philosophic treatment with
't\rhich so many questions were discussed by the ancients.
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Currier defined the menopause as the condition which exists and
the

collecti~

phenomena which appear in conneotion with the cessation

of menstruation.

This cessation takes place gradually in most cases, the

intervals between the menses lengthening, and the latter finally failing
altogether, after a period from one to three cr four years.
time, the phenomena are varied in character.

During this

With some women there is

scarcely any consciousness that anything unusual is occurring aside from
the fact that the inter-menstrual intervals are longer than usual.

With

other iIIIomen, the hemorrhages, if less frequent, are much more profuse.
The nervous system may be unaffected or there may be disturbance of both
cerebro spinal and sympathettc systems.

Vasomotor disturbances are

extremely common, and mental disturbances are by no means rare.

In cases

in whioh there is predisposition to the development of new growths, such
growths may develop at this' time •
Atrophio changes take place in all the genital organs as the menopause progresses.
Finally, the menopause may be as uneventful as any of the other
necessary exper iences to whioh the femal e economy is subjected, but it is
also susceptible to variation as far as possible in the opposite direction.
While Tilt considered the menopause as a serious, critical time in
a woman's life, Currier

'W!':l.S

prone to consider it a normal, physiological

process through which every normal female must pass.
writers at this

th~e

In fact, nearly all

were beginning to become more conservative as to their

ideas regarding the menopause.
Treatment of the menopause as outlined by Currier, shows very little
improvement or advance as compared with that ef Tilt.

Currier's outline

consisted chiefly of' sedatives I bleeding to relieve congested organs, and
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curettage.

In conclusion, Currier says, "There is little additional

which can be said in regard to the general treatment of those who are
passing through the menopause.

Those who are not sick, but think they

are, must be disillusioned with gentleness but fi rmness.

They must be

assured that the process is a physiological one through which the great
majority of women pass unharmed; and yet the

unusu~l

sensitiveness of

both body and mind at this juncture must be fully recognized and proper
caution enforced against all means which could destroy the sensitive
equilibrium.

Those who are sick must be treated upon rational principles,

not by superstition or tradition.

Surgical conditions should be recog-

nized promptly and promptly treated and those "'ho are susceptible to
relief by drugs should receive remedies which are

trie~

and reliable,

not the nostrums and cure-aIls of the quacks It.
In 1921, Emil Novak published his work on the disorders of

menstruation in which he imcluded a detailed aiscussion of the menopause.
The advance between the time of Currier and Novak is remarkable.

Novak

regards the menopause as marking the termination of the reproductive
stage of a WOffian's life, tl1e most prominent clinical manifestation of
this transitio.."1 period being the cessation of the menstrual flow.
In Novak's experience, he found that more women ceased to menstruate

between the ages of 45 and 50 than between the ages of 40 and 45, the
average being about 47 years.
Speaking generally, it seems to be true that the earlier the
menstrual :f\mction is established, the longer it will continue.

In other

words, if puberty occurs at an early age, the menopause is likely to be
late in its appearance, the reverse being, equally true.

/
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According to Sanes, the climacterium is usually late in the case
of women who have led an active sexual life, especially if they have given
birth to a number of children.

On the other hand, it is likely to occur

early in unmarried ViOmen.
As a rule, the menopause occurs earl ier' in the women of cold

climates than in those of the tropics.
An unusually early or unusually late menopause is said to be noted
in certain families as a hereditary trait.

Examples of such families are

cited by Currier and others.
The menopause, as a general rule, occurs earlier in poor, hardworking
women than in those living in idleness.
The menopause is frequently seen at an early age in stout women.
Cases of this type are now looked upon as due to a deficiency of the
pituitary secretion.

The two most prominent symptoms encountered in

these cases are obesity and sexual hypoplasia, manifesting itself in the
woman as scanty menstruation or an actual cessation of the process.
General diseases ass ociated with wasting and general debility tend
to bring about an earlier menopause than usual, the cessation of the
funct;ion in such cases being apparently an effort on the part of nature
to conserve the strength

0

f the woman.

In the great majority of cases, the effect of local disease in
the pelvis is to delBythe occurence of the menopause.
Tilt has published a very interesting ta.ble as to the approximate
age at ymich there is a cessa.tion of menstruation.
on the follO'tvi ng pe.ge;

I shall include it
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-----------------------------------------------------------------------------Paris
London
London
Total cases

Age of cessation

B. De Boism.ont's Guyts
Tilt's
--------------------eases _____________ cases ______ cases ________________________
21st year
22nd
"
ff
25th
It
26th
tI
27th
It
28th
II
29th
If
30th
tI
31st
II
32nd
It
33rd
II
34th
tl
35th
II
36th
37th
"
38th
"II
39th
It
40th
41st
"
42nd
"II
43rd
44th
"
II
45th
If
46th
47th
"
It
48th
II
49th
tt
50th
It
51st
52nd
"
tt
53rd
It
54th
It
55th
It
56th
fI
57th
ft
58th
59th
"tI
60th
It
51st
Total

2

2

1

1

1
1

1

1
1

1

1
1

3
2
4
6
7

1
10

1
3
2
1
11

4
4

6

2
1
3

1

3
7

1
5
5
7

2
'7
6

2

6

15
10
16
18
18

4
7
1
18
10
7
4
13
13
49
13

33
24
24
23
24
45
34
25

8

38

'1

25
37
14
13

27
16

2
5

8

9

2

7

19
14

2
2
2

1

2
1

6
4-

8

2
4

5
4

1

...

12
4
8

181

~-

400

10
42
17
26
24
23
49
31
42
37
32
49

93

51
57
51
60
107
74

eo

83

64
98
45
'Sf
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1

1

1

2

2

2

5m--

Average age of cessation (1082 cases) - 45 years 9 months.

lO82-

The

average duration of the menstrual fu.nction was found to be 28.95 years
by B. de Boisntont, and 31,33 years by Tilt.
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There are marked individual variations in the duration of the
menopausal perieXi.

It must be borne in mind that the cessation of the

menstrual function is only one# though perhaps the most striking, of a
whole group of changes which mark the retrogression of the reproductive
function.

Properly speaking, the menopause embraces all these various

phenomena and from this viewpoint, its duration is from a few months to
several years.

The average duration may be placed at from two to two and

one-half years according to Novak.
As the woman approaches the climacteric age, even while the
menstrual function is still regular, she is likely to experience more
or less of the vasomotor disturbance "J'Jhich, next to the disappearance
of the menses, is the most important manifestation of the menopause.
From time to time, there will be an intense though transitory flushing
of the head and neck, accompanied by a sensation of flashing heat.
is frequently followed by sweating, sometimes copious.

This

The temperament

of the woman is quite likely to undergo some change though only exceptionally, is this very profound.

Usually this change is evidenced only

by unusua.l nervousness, irritabilitYII and peevishness.

By thi.s time,

there has probably been more or less disturbance of the menstrual rhythm.
Whereas the menses have been recurring at regular £our week intervals,
and have been lasting perhaps four or five days, they now become usually
more scanty, }a,st:i.ng only a day or two.
skipping of one period.

There may be even a complete

This may be followed by sca..nty menstruation for

a month or two, and then will come another period of amenorrhea.

In this

gradual manner, the menstrual function tapers off into complete disappearance.
The vasomotor symptoms usually continue for a longer or shorter time after

8

the cessation of menstruation, their disappearance also being gradual
as a general rule.

In the majority of cases, there is a tendency to

laying on of adipose tissue, sometimes amounting to an actual obesity.
This is the typical course .of the menopause.

However, the symptoms

may be so slight as to be scarcely noticeable and in other cases, they
m2.y be very severe.

As before, it is stated that the duration of the

symptoms varies greatly.

The psychic changes may go on to insanity

thouGh rarely is this true.
All the anatomic changes demonstrable in various organs at the menopause are

L~dicative

this period.
vulva.

of the universal retrogression which characterizes

Marked atrophic changes are seen in the tissues of the

The fat of which the labia are so largely composed disappears

almost entirely, so that they become little more than two long skin folds.
The clitoris becomes very small.

As a result of the so-called senile

atrophy, with its attendant thinning of the epithelial layer, the mucous
membrane of the vulva loses its velvety, vascular appearance, and becomes
thin, pale, and transparent looking, giving the surface a rather pasty
appearance.

The vagina becomes narrow and contracted, the result of the

same process of senile atrophy in which there is a replacement of parenchymatous by interstitial tissue.

The va.ginal mucosa like that of the

vulva, becomes thin and atrophic. The cervix becomes very small and
short.

The uterus also becomes very small and hard, the endometrium

becomes thin and avascular.

The fallopian tubes also participate in the

retrogressive processes of the menopause, becoming shorter and thinner.
The fim.briae disappear or becorr.e very inconspicuous as do also the
longitudinal rugae in the mucosa.
in the maj ority of cases.

The size of the ovary is much changed

The surface is not glistening as in the case

of the young woman, being now of an opaquely white appearance.

The
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peculiar wrinkling at this time resembles the surface of a peach stone.
The mammary glands also becane small and atrophic in the majorit'lJ of
cases.
With the foregoing discussion serving to introduce the menopause in
general, a more detailed dis cuesion of therapeutic measures iNil1 be
attempted in the following pages.
The higher the standard of general health and resistance with which
the woman enters upon the menopause, the better her clu'lnce of passing
through it with a minimum of discomfort.

It is scarcely necessary to

discuss at any length the importance of such factors as care in diet,
proper sleep. bathing, avoidance of constipation, and especially, the
avoidance of worry and anxiety of any sort.

Strict insistence by the

physician on the carrying out of these measures and an intelligent
cooperation on the part of the patient, will do much to relieve the
suffering of the woman who is passing through' this trying period.
The wcman Vlho approaches the menopause in good physical health is
muoh less likely to suffer severe disturbances than the one who arrives
at this period worn out by physical disease,
oares J anxieties, and other such caus as.
avoidance of worry and anxiety,
to fall upon the

WOI:1m"!.' S

every possible way.

ID&l.Y

child births, domestic

Of special importance is the

The brunt of the menopausal storm seems

nervous sys tem and this should be spared in

Members of her f81nily should be urged to show her

every consideration in this trying period whenever pronounced temperamental
c~anges

me,y make theD',selves apparent.

Drugs are almost always neoessary in addition.

.-

Of' sedative drugs,

those in most common use are opium by mouth, and the bromides, phenobarbital and similar drugs.

To secure sleep, it is a]most always necessary

10
to give s orne hypnotic such as barbital, medinal
paraldehyde.

$

sulphonal, chloral, or

Sometimes alcohol at bedtime will secure sleep.

In the

majority of cases, Eliy.ir triple bromide will give very good results the dosage depending upon the severity of symptoms.
The most recent

adV13-12CeS

in therapeutics have been made along the lines

of endocrinology, the results in some cases having been gratifying and in
others, very disappointing.
The ova de s have a twofold functi on.

First~

-they have an excretory

function of producing and discharging ova, and second, an incretory function
of regulating the growth and maintaining the function of the genital organs.
In 1827, Von Baer demonstrated the mechanism of ovulation, and for long
after, it was believed that the stimulation of this process accounted for
those phenomena that are now known to be the resu It of internal secretions.
The present knowledge of the physiology of the famal e reproducti va
organs was initiated by :Knauer who, in 189B, showed in experimental
animals, that transplantation of ovaries prevents the usual atrophy of
the uterus that follows ovarian extirpation.

This experiment proved that

the ovaries must produce an internal secretion which, acting through the
medium of the blood, preserves the integrity of the genital organs.

Knauer f s

conclusions were immediately verified by other investigators (Grigorieff,
Ribbert, and Rubinstein).

In the year 1900, Halban added a new and

important phase to the sUb.ject by sho'wing that if an iF-mature female
guinea-pig is castrated and an ovary transplanted subcutaneously, normal
puberty occurs.

This proved that the ovaries produce an internal secretion

that governs the anatomical and physiological development of genita 1
organs, and a.lso for the atrophy with ovarian dysfunction at the menopause.
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Clinical attempts !:l.t substitution therapy were ID!lde by

a~ministerir.g

ovarian extracts for all kinds of menstrual di Borders but w'i th little
success - a failure which has clouded the career of ovarian hormonology
up to the present time.

But the result of anirpal exper mentation with

these same extracts has been a different and remarkable story.
Adler in 1912 was the first to produce segual activity in ovariectionized animals by the injection

0

f watery extracts of ovary.

Adler I s

work marks the turning point in the history of the seareh for the ovarian
hormone.
Most people thought of the internal secretion of the ovary as a single
substs.nce but were perplexed at the multifarious and contradictory fUYlcti ons
of which it ",vas capable.
The final triumph of the female sex hormone came in 1928 "When Allen and
Doisy in this country, and a few months later Butenarrlt in Germany,
announced the isolation of the hormone in crystalline form from the
follicle.
But there were als 0 many doubters who still bel iev-ed that the oorpus
luteum must elaborate a specific hormone entirely distinct from that of
the follicle liquid.

Corner, in 1929, settled this question beyong dispute

when he isolated the corpus luteum hormone which he called "progestin If.
The relationship of theelin and progestin will be discussed later.
Allen and Daisy identified the follicular extract by the changes it
produced in the uterine and vaginal epithelium of rodents.
was also standardized by this means.

The extract

The vaginal smear from a ra.t' s vagina

at rest or atrophied from castration consists chiefly of leukocytes.

Under

the influence of natural or artificial oestrous, the smear shows great
numbers of non-nucleated squamous epithelium.

The rat unit as defined by
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them is the Ithighest dilution of an extract which, when given to a mature
spayed rat in three injections at four hour intervals during the first day,
will result in cornification and desquamation of vagina:;, epj;thelium on the
morning of the third day".
Corner established a test for the corpus luteum secretion similar in
nature to that used for tho tollicular secretion.
carried out as follows:
is subjected to removal
of the uterus.

Corpus

The experiment was

A doe rabbit is mated and eighteen hours later

or

both ovaries and the exoision of a small portion

lute~~

extract is administered for five days and on

the sixth day after mating, the animal is killed, the embryo recovered if'
present, and the uterus submitted to histologic examination and comparison
with the specimen removed at the time of castration.

Under the influence

of the extract, the uterus undergoe s the character istic progestational
ch8.nges.

To the eye and under the microscope, the

00

:n:'l.i tion 9f such a

uterus csn in no way be distinguished from that of normal pregnancy of the
fifth or sixth day except that a.fter large doses, the proliferation may be
even greater than in normal pregnancy.
The same experiment was perfor-reed using folliculin ~theelin) instead
of progestin, but nons of the progestational changes could be produced.
The syrlergistic relationship between the fo11ic Ie and corpus luteum
has been demonstrated by a number of striking experiments.
Corner and Hartman, working separately on the sex cycle of menstruating
monkeys, both found that these primates sometimes menstruate in regular
course without any precedi ng ovulation or corpus luteum formation in the
ovaries.

The endometrium in such cases doe s not show the pre-menstrual

changes typical of true menstruation

folloVc~ng

ovulation.

They

the~efore

,-

concluded th..at in primates at least, there are

tv~

types of menstruation,

one where there is ovulation, and a pre-menstrual grmrth of endometrium

13
and one

~fuere

these changes are absent.

They then injected theelin into

castrated monJ;:eys and produced menstruation, but without the pre-menstrual
proliferation of the mucosa.

Corner. and also Hisa"1lJ, next tried sensitizing

the mucosa by injections of theelin and then following this
of injections of progestin.

~~th

a series

After this double treatrrcent, true menstruation

ensued with characteristic pre-menstrual proliferation of the mucosa.
FraIn this experiment, -chey reasoned that the function of the follicular
hormone seems to be that of putting the uterus in the proper physiological
condition so it can respond to the corpus luteum hormone.

Neither of these

substances can produce progestational proliferation in the castrate uterus
when given alone.

If, however, it is first brought into condition typical

of oestrus through the injection of follicular hormone, and is followed
immediately by corpus 1uteum treatment, progestational proliferation results.
We ceme now to a relationship between the internal secretions of the
ovary and those of the hypophysis.

Knowledge that such a relationship

exists dates back to 1901 when Frelich described his famous syndrome of
hypo-pituitarism, adiposogenital dystrophy. and hypo-sexualism.
Later experiments by Zondek and Asohheim proved that by transplanting
a fresh piece of anterior lobe in an infantile mouse, a condition of oestrus
was invariably brought about.
On the other hand, anter ior lobe transplantation has no efFect on

the vagi:..YJ.B. and uterus of an ovariectomized animal.

In a normal animal, it

causes oestrus and also ovulati on and luteinization in the ovaries.
It was soon found that tl'O substances were conta.ined in this pituitary
extract as the same result was not always obtained.

The two substances were

isolated - chiefly by Zondek and 1}lrere called Prolan A and Prolan B, Prolan A
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being a follicular ripening hormone and Prolan B a luteinizing hormone.

Zondek also holds that there are two other substances contained in the
anterior lobe, and summarizes the situation a's follows:

1.

Growth hormone

2.

Prolan A

follicular ripening hormone.

3.

Prolan B

luteinizinl!<.' hormone.

4.

Metabolism hormone.

PItOLAN

Zondek, after making this discovery, correlated the pituitary hormones
wi th thase of the ovary as fol101liTs:

1.

The female sexual function manifests itself in the fol1crwing 11Iray:

the anterior lobe of the hypophysis is the motor of the sexual function and
the hormones of the anterior lobe are the superordinated specific hormones

,-'

of sex.
2.

Prolan A sets off follicle ripening and incites the theca cells

of the follicle to the production of folliculin which in turn induces the
proliferative phase of the endometrium.
3.

Prolan B effects the chan ga of the granulosa and theca cell 5 to

lutein cell sand inoi tea in them the production of pro gestin which. changes
the proliferative phase of the endometritun to one of secretion (pre-menstrual,
pregravid, pregestational stage.)
Correlation of the hormones of the hypophysis and the ovary are
very wall illustrated in Zondek's diagram, appearing in Gravers work on
the female sex hormone B.nd illustrated on the following page.

15
Gl'Qvvth hOt'tllC1"~.

/

--...

(6)

1l'iJ I; ray<.1 i it'~
5taf'fe

1i\(1.m~nstl"u ~,
5iJ~It.

Prolan A, starting from the hypophysis stimulates the growing:
follicle to the produntion stage of folliculin which" in turn, stimu~ates
the proliferative stage of't'he endometrium. A small run.ount of folliculin
is excited in the corIUs luteum as irrlicated by the broken line. Prolan B
sti~~lates the lutein cells of the corpus luteum to the production of'
progestin. The hypophysis also elaborates the special' growth hormone and
a probable metabolic hormone.
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Frank found that the urine and serum of women eoing through
the menopause, contained little or none of the female sex hormone using the vaginal smear test of Allen and Doisy.
:Bearing in mind the foregoing facts, the cliniccl.1 application of these extracts will be discussed.
The premise that menopause symptoms are associated with
a cessation of ovarian function is both reasonable and logical.
As a cor,ollary, it may be stated that the loss of the dominent
ovarian secretion - the female sex hormone would appear to be
a most important factor, although the increase in pituitary
hormone must be taken into account.

On this basis, attempts

to replace this loss of female sex hormone by a substitution
therapy are surely indicated.
Since so many hormones have been identified and described
it is unreasonable to believe that anyone hormone alone can
be responsible for the symptoms encountered in the menopause.
It will be necessary as pointed out by Frank and others, to
analyze chemically or by other means, and to determine in just
what hormone or hormones we are lacking, and to substitute
a.ccordingly.
According to Frank, in addition to the usual clinical examinations, which in those cases which are worked up, include
a careful history, anthropometric measurements, basal metabolism, differential blood count, and, when indicated, sugar
tolerance, seller roentgen and visual field examinations,
certain hormone tests should be performed.
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The hormone tests which Frank advocates in properly selected instances include "the evaluation of the female sex hormone
blood level thruout a cycle, or, if no periodicity exists,
over a. period of from five to six weeks, with simultaneous determination of the hormone excretion through the urine.

Tests

for the prepituitary hormone have been studied, but thus far
no satisfactory results have been obtained.

The tecnics for

the female sex hormone are now sufficiently standardized to
permit the study of a considerable number of cases each month
in small laboratories not pessessing special equipment.
The treatment of menopausal symptoms has yielded varying
results in the hands of different gynecologists.

Kurzok offers

an explanation for this in his paper on "Follicular hormone in
the urine as an index of therapy in the menopause."

Kurzok

found that those patients who are not benefited by ovarian
therapy have ovarian hormone in the urine while those that are
benefited have none.

Kurzok has determined that every normal

woman during her active sex life excretes from ten to twenty
rat units of follicular hormone per liter of urine.

This level

of excretion is fairly constant, though there are minor variations within these limits during the menstrual cycle.
Kurzok has grouped, cases of

m~nopause

as follows:

(1) No ovarian hormone found in urine.
(a) Artificial menopause (x'ray or operation)
(b) Some cases of spontaneous menopause.
(2) Ovarian hormone present in the urine.
(a) Some cases of spontaneous menopause.
The subjects that show no ovarian hormone in the urine
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are very distinctly benefited by therapeutic injection of the
hormone, while those that show ovarian hormone in the urine are
not at all benefited by the treatment.

When both ovaries have

been removed at operation or when sterilization due to radiation
is complete, no follicular hormone is to be

f~und

in the urine.

In the spontaneous menopause group the subjects that menstruate
normally and have menopausal symptoms, ovarian hormone is always found inthe urine, and the administration of more ovarian
hormone is of no benefit.

'Vhen the patient menstruates in-

frequently and the excretion of ovarian hormone is sporadic, then
follicular hormone is beneficial.

In subjects that are not men-

struating, follicular hormone mayor may not be found in the
urine; it is only in the latter group that good results are ob..~

tained.
All cases of menopausal symptoms are investigated and treated
in .the following way:

A twenty-four hour specimen of urine is

collected from 7a.m. to ?a.m. The ur.ine collected at ?a.m., At
the end of the 24 hours is kept in a separate bottle.

The

larger quantity of urine collected on the previous day is subjected to a quantitative follicular hormone determination.

The

separate morning specimen is tested for the presence of gonadal
stimulating hormone, prolan A, by the method of Zondek.

When

ovarian function has ceased the findings are as follow. : Ovarian hormone, negative; prolan A, positive.

Zonkek has shown

that when the ovaries cease functioning prolan A immediately
appears in the urine.

On the other hand, if the ovaries are
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functioning ovarian hormone is found in the urine and prolan A is
absent.

Only when there is no ovarian hormone in the urine

according to Kurzok is theelin indicated as a therapeutic measure.

There is apparently no reason for injecting ovarian hor-

mone when the patient is already excreting considerable quantities of the hormone in her urine.
Kurzok treats patients having hormone in the urine by means of triple bromides and calcium lactate, the purpose being
to depress the irritability of the vasomotor and the other centers involved.
Theelin has been given orally to women, whose urines were
followed for its excretion over a period of one or two months.
Eight cases are reported by G.V. and O.W. Smith, which includes
four amenorrheic patients, three sterile and one normal c;ontrol.
The results would indicate that in women as in rabbits theelin
is excreted only when the organism has been exposed to the
action of corpus luteum.

It appears possible by this means to

differentiate between a persistent corpus luteum, irregular
appearance or total absence of corpus luteum, and cyclic activity of the corpus luteum.
In Kincaid's experience there are two types of patients
who may be benefited by ovarian therapy:

The sterile woman

who has not conceived, apparently because of the lack of sufficient ovarian hormone, and the woman suffering from the symptoms so often seen at the beginning of the menopause.
Kincaid reports three cases of menopause occurring pre-
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maturely in which he used theelin in massive doses(lOO rat units
a day for 6 days). Gratifying results were had in all three cases.
Two objections are generally raised regarding the hypodermic use of theelin:

first, the need to use a needle and the

necessity of monthly repetition.

A third objection can be

raised, namely, the cost of the preparation which, judged by
usua.l drug prices, is high.

The patients generally feel however

that the injections are worth the cost, and readilly submit to
monthly injections when necessary.

The local reaction from hypo-

dermic injection has been found to be very slight in amount,
and not contraindicative to its use.
Kincaid closes his paper with this statement: "It seems
from my experience, that any woman is entitled to a tria.l of
treatment with follicular hormone, who presents her self to her
physician, giving a clear cut history of diminishing menses accompanied with subjective symptoms of the menopause, in the absence of any other demonstrable pathologic conditton.
Definite conclusions cannot be drawn from three cases, but
it is further testimony that ovarian therapy is meeting with
a certain degree of success.
King of Johns Hopkins has published a paper in which he
attempts to compare the therapeutic effect of ovarian therapy
with tha.t of bromides and pheno barbital.
corded as follows:

The results were re-

If symptoms disappeared entirely under treat-

ment the result was expressed as "plus 106;11 if the symptoms
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were much improved as "plus 75;" improved substantially "plus
50;" slightly improved, "plus 25;"

If 'symptoms became much

worse under treatment the result was entered as "minus 100;"
rather severe exacerbation of' symptoms was called "minus 75;"
less severe "minus 50;" slightly worse under treatment "minus
25."
Phenobarbital was used essentially to control the results
of ovarian treatment, its use justified by the vasomotor and
neurogenic nature of menopause symptoms.

Phenobarbital gave

somewhat better res't,llts (plus 33.7 per cent) than those obtained from ovarian substances as nearly as could be estimated.
In a smaller number of observations (eleven) there was no
exacerbation of symptoms under bramide therapy. This group
claimed the greatest degree of improvement (p1us47.7 per cent)
However, the number of cases in this group is smaller than
those in the other groups except the follicular extract group,
which also contains eleven observations.
In the corpus luteum group 28 observations were made on
17 different patients.

A standard preparation was given by

mouth in the usual dose ( one 5 grain tablet t.i.d.) or in
double the usual dose.

The results show an average improve-

men't of 19.6 per cent, which is not so good as the results
with phenobarbital or bromides.
Whole ovary ( 5 grain tablets t.i.d. ) showed improvement
of 22 per cent in twenty five observations.
Follicular extract 5 to 25 rat units daily was used in
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a group of eleven patients in this series, the beneficial result
was estimated as "plus 9.1 per cent."
Corpus luteum increased the basal metabolic rate 3.1 per
cent, whole ovary produced no change.

The follicular extract

decreased the basal metabolic rate 3.6 per cent.
From these results the following conclusions were drawn:
1. Corpus luteum and whole ovary by mouth and follicular
extract subcutaneously are probably useless in the relief of
symptoms of the menopause.
2. Bromide or phenobarbital or a combination of the two
is distinctly helpful in the treatment of such symptoms, probably not specifically but as general mild sedatives.
3. Corpus luteum may raise a low metabolic rate in a
patient at the menopause, but this effect is not suffiCiently
striking or constant to warrent definite conclusions.

Fresh

whole gland and follicular extract seemed to have no significant
effect on basal metabolism.
Before considering the foregOing conclusions too seriously
it must be borne in mind that this work was completed in 1928 t
much advance has been made since that time.

I do not believe

that doses of follicular extract ranging from 5 to 25 ·rat units
daily are sufficient to draw any conclusions.

As will be po-

inted out later doses of follicular extract consisting of 100
rat units daily have been given with gratifying results.

Further-

more it has been definitel.y shown by research workers in the
past few years that the older commercial preparations of corpus
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luteum and whole ovary had very little or no potency.

This fact

has been generally recognized by gynecologists thruout the country and has led to a closer union between the clinician and
research worker,

I shall refer to these results later in this

paper.
The effect an the basal metabolic rate is significant, and
prooves only further the interrelationship of the endocrine
system.
As pointed out by Schoeller, Dohrn and Hohlweg animal experiments have clearly shown that the complete developement
of female characteristics in an individual is only to be expected when the follicular hormone is produced in adequate amounts.
Follicular hormone therapy is therefore, justifiable in all
cases due to ovarian hypofunction.
Climacteric changes form the chief indication for follicular hormone therapy, and it will also favorably influence conditions due to partial or complete artificial suppression of
ovarian function.
In this connection the relief of vasomotor disturbances,
which form a frequent and distressing SjEptom, is most important.

The symptom complex is not, however, confined to the

cardia vascular system.

Cutaneous manifestations such as prur-

itus and eczema, intestinal symptoms in the form. of severe constipation, arthritic conditions Which are refractory to antirheumatic treatment, are all met with and form a most faTor-
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able field for substitution therapy with the follicular hormone,
mental changes, especially the frequently occuring psychic depression, are also benefited.

Here the generalized tonic eff-

ect of the follicular hormone undoubtedly plays an important
part since, in addition to readjusting local disturbances, it
produces a condition of euphoria which is in full harmony with
the somatic regeneration which sueeessful hormone treatment produces in women.

This general rejuvenation has also been ob-

served in elderly women in whom the climacteric symptoms have
already subsided.
In contrast to the results reported by King, I shall present 25 cases reported by Geist .and Spielman of New York. Theelin was used in all cases.

Theelin represents the purest pro-

duct obtainable, and assays as labelled, 50 rat units per c.c.
The preparation was administered by intramuseular injection in increasing doses beginning with 50 rat units three times
weekly.

The patients were always carefully interviewed regard-

ing the effects of injections in regard to exacerbation or improvement of symptoms.

Before treatment complete physical ex-

aminations, blood pressure readings, complete blood counts, basal:~.metabolism,

x'rays of sella turcica and joints when indicated,

and weight were recorded.

The symptoms which were stressed and

which were usually present were hot flushes, sweats, headache,
joint pains, insomnia, palpitation, libido, paresthesias, and
psychic disturbances.

The majority were observed and treated

from four to eighteen weeks.
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The results were as follows:

Four of the twenty five cas-

es were markedly improve.d, eight were slightly improved, in
eight there was no improvement at all and in three there was
improvement with bleeding.

Type total

Markedly
improved

Slightly
improved

Unimproved

Improved
with bleeding

-------.--..--------------------------Natural 14
Artificial 11

4
()

4
4

3
5

:3

o

The eight cases reported as slightly if at all improved
are of little value.

For the sake of accuracy they have to be

designated as improved.

As far as improvement in the individual

symptom is concerned, it was found that the joint pains were
almost never improved, headaches rarely, sweats only with improvements in flushes; palpitation, paresthesias, and insomnia were
improved more often.
It is interesting to note that the natural menopause appears more amenable to treatment than the artificial of the 14
cases treated eleven were improved, seven markedly so.

Here also

it was observed that in three' of these cases the menstrual periods were reestablished with complete alleviation of symptoms.
In later case reports we shall see however, that much success has been had in the treatment of artificial menopausal
symptoms, it is apparently a question of dosage.
In order to illustrate just how these cases were managed, I shall present the cases reported by Geist and Speilman.
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Case 1. A. S. aged fifty, married, natural menopause, Aug
Symptoms were as follows: Flushes 20-30 per day, aCCOMpanied by sweats, headaches present for fifteen years, worse'
since menopause. Joint pains also present for fifteen to twenty
years. Physical examination negative. Blood pressure 135/105
Weight 150. Urinanalysis essentially negative. B.I.R. negative.
Blood count showed hemoglovin 65 per cent. and lymphocytes, 52
per cent, otherwise normal. She was treated with sedatives, at
first, then thyroid with impDovement. She received 14 injections of theelin, from February 19 until Mar 12, 1931, in increasing doses up to 150 rat units per injection. There was slight
improvement.
1928.

Case 2. E. B. Aged forty three, married natural menopause
Jan, 1930. Complained of flushes 1-2 per day, sweats not marked,
headaches, ,j oint pains, occasional insomnia. Physical examination except for a blotchy skin with acne was essentially neg.
B.P. 136/80. Blood count normal. B.Y.R. minus 3 per cent.
Urinanalysis neg. She received 166 rat units per injection.
She stated that she felt better, but origional symptoms were
very mild.
Case 3. E. G. Aged thirty-eight, married, natural menopause Dec 15 1931. This patient complained of three flushes per
day, occassional headaches, joint pain in left shoulder, present before cessation of menses. Slight palpitation, psychic
disturbances, insomnia. Libido present. Physical examination
negative. B.M.R. minus 4 per cent. Blood count normal. B.P.
normal. She received 14 injections from Mar 3 until May 25,
1931. There was slight improvement in symptoms, which were
origionally mild.
Case 4. A. S. Aged 47, married, weight 147, natural menopause, Jan 30, 1931. Symptoms appeared Sept, 1930. Flushes
every half hour, sweats, headaches, joint pain in right shoulder,
palpitation, marked insomnia, libido absent. Physical examination essentially negative. B.P. 142/78. B.M.R. minus 21 per
cent. Urinanalysis neg. Theelin was begun April 18, 1931 and
was continued until April 27, 1931, she received 6 injections
with slight improvement. In view of the B.M.R. minus 21 per
cent, she was placed on thyroid gr 1/4 t.i.d.
Case 5. R. L. Aged 47, married natural menopause Aprll
Symptoms began about that time. They included flushes,
profuse sweats, headaches pain in left knee, psychic disturbances and insomnia. Blood count and basal metabolism were not
done. Physical examination negative. Patient still has occasional periods of bleeding. She received theelin from April 27,
1931 to June 8, 1931, receiving 9 injections up to 250 rat units
per injection. She improved so that all symptoms disappeared
except the j oint pain. 'She then bled from :May 23 to :May 26.
1930.
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When seen subsequently, she was having only 2 mild flushes per
day. In this case the improvement associated with the bleeding
was so marked that further treatment was stopped.
Case 6. R. R. Aged 43, married, natural menopause Feb
15, 1931. Symptoms immediately after this inoluding frequent
flushes, severe headaches, joint pains inelbow and palpitiation,
and insomnia. Physical examination essentially negative. B.P.
165/100. Weight 191. B.M.R. minus 25 per cent. Complete blood
count normal exoept for eosinophiles of 5%. She received theelin from June 8 until Aug 20, three times a week, 9 injections
all together up to 300 rat units per injection. Symptoms were
mild. Under treatment they completely disappeared according to
her statement at the last examination. This patient was very
cooperative and very grateful for the treatment received. This
probably influenced improvement considerably.
Case 7. A. K. aged 42, married, natural menopause five
years ago. Complaired of flushes every half hour, sweats, backache, palpitation, insomnia, libido absent. B.M.R. plus 16%.
Complete blood count normal. B.P. 165/115. Physical examination
essentially negative. Reveived 8 injections between Aug 31
and September 26, 1931, dose gradually being increased to 300
rat units per injection. This patient improved considerably.
At the last examination, no other symptoms except palpitation
were present.
Case 8. A.M., aged 40, married, natural menopause, period
in December, 1930, then Mar 4, 1931. She complained of flushes,
sweats, pains in the elbow and feet and palpitation. Some insomnia. Physical examination was negative. B.M.R. minus 3%. Urinanalysis negative. Blood count normal. This patient received
7 injections of Theelin up to 200 rat units per injection from
April 13 to :Uay 11, 1931. During which time she had two episodes of bleeding with complete alleviation of symptoms. As
she was menstruating treatment was stopped. Theelin was probably a factor in causing the bleeding. Her symptoms aside from
the time she was bleeding, were only slightly improved.
Case 9. B. B;', age.d 44, married, natural menopause June;,
1930. Symptoms appeared August, 1930, complained of flushes
five times daily, headaches, joint pains in arms, leg and back,
palpitation, psychie disturbances. Libido always absent. Physical examination negative. B.P. 156/90. B.I.R. minus 4%.
Blood count except for 43% lymphocytes was normal. Urine 'negative. She received 15 injeetions of theelin up to 150 rat units per injection. She showed some improvement. Flushes were
reduced to 1 or 2 per day and other symptoms were also improved. She also reported increased libido. She then had a period
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in April and another period in May. Treatment was discontinued
as symptoms disappeared with the bleeding.
Case 10. D. L. aged 44, married, natural menopause May,
1929. Symptoms immediately afterward including moderate flushes, some sweats,heatiache, stiffness in the joints, moderate
palpitation, and insomnia. Libido present. Physical examination negative •. B.P. 160/90 weight 149. B.lf.R. minus 2 and 1%.
This patient from the very beginning showed a marked globus
hystericus with associated nervous symptoms which were entirely
uninfluenced by treatment and were based on difficulties at
home with her grown children. She r~e.'Ted 15 injections between Jan 12 and Feb 16, 1931, in increasing doses up to 125 rat
units per injection. Improvement was marked, the only symptoms
which persisted were joint pains and insomnia. Hysterical condition was not affected, but patient responded very well to
the interest sh~ in her case which probably influenced the
improvement.
Five cases of a.rtificial menopause are also reported, but
since little or no relief was obtained it is not necessary to
include them in detail.
In two cases of kraurosis marked improvement was .noted
using theelin in increasing doses.
The following conclusions were noted:
1. The evaluation of improvement or non-improvement in
menopause symptoms as a basis for judgment of the efficacy of
the preparation was found to be exceedingly difficult.
2. Seven menopause cases of the 25 patients were definitely improved, 3 with the reestablishment of menstruation.
'he others were either unimproved or so slightly improved as
to be negligible.
3. Two patients with kraurosis on whom VUlvectomy
had previously been performed showed marked improvement of the
itching.
4. In several cases of natural menopause, bleeding,
possibly menstruation, followed the injection of theelin.
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5. The natural menopause seems to be more amenable to
treatment than the artificial climax.
6. Substitution of the female sex hormone alone soes
not in all cases relieve the menopause syndrome.
7. Other factors such as reduction of the quantity of
the quantity of anterior pituitary hormone may improve the result.
Werner and Collier in studying the effect of theelin injections, (200 rat units daily, for 28 days, 300 rat units daily
the second 28 day period, and. 400 rat units daily the third 28
day period) on castrated women, report the following results:
1. Theelin restores the breasts and genital tract of
women to apparently the normal

sexu~l

state after previous

castration atrophy.
2. Theelin produces changes in the atrophied endometrium of castrated women that apprOXimate or equal the interval changes found in the normal women at the time of ovulation.
3. Theelin does not produce the pregravid changes
in the endometrium of castrated women.
4. The bleeding from the uterus of castrated women
induced by theelin occurs from an endometrium approximating or
equaling in development the interval changes found in the uter,

us of. normal women.
5. Theelin induces bleeding from the uterus of castrated women qualitatively indistinguishable from menstruation

"~

in normal women.
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6. This bleeding from the uterus of castrated women

is accompanied by the subjective symptomatology usually experienced by normal women during menstruation.
?

Theelin relieves the subjective symptoms that occ-

ur in women following castration.
S. Four ovariectomized women to whom large doses of
theelin were given state that "libido was markedly increased."
9. Excessive doses of theelin were given to women intramuscularly over a period of from eighty nine to ninety three
days without seeming discomfort, until a dosage of 300 to 400
rat units daily was reached.
It is evident that the marked difference in results obtained by Geist and Spielman as compared with those obtained
by Werner and Collier can be explained upon a basis of dosage.
It is evident that castrates should require more hormone than
those in which the ovaries are intact.
In a recent

st~dy

of menopausal cases Sevringhaus calls

to our attention these facts.

In a series of 32 menopausal

cases hot flashes occured in all, paresthesias in 16, insomnia
in 19, and Jsychotic pictures in l?
only 13, and

hypert~nsion

in 10.

Obesity was found in

Of this series 6 had artific-

ial climacteric produced by radiation or surgery, and there
~~

were 3 patients with a spontaneous premature menopausal picture,
possibly to be considered as ovarian insufficiency.
The use of simple psychotherapeutic procedures and small

~.

doses of folliculin daily or oftener has been found very help-
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ful in the psychotic cases as well as in the simpler vasomotor
types and the pseudothyrotoxic types.

The value of frequent

small doses rather than large doses at longer intervals in
certain selected cases will be pointed out subsequently in this
paper.
Hamblen has reported 40 cases of menstrual disorder in
which he used follicular and hypophyseal hormones.

With the ex-

ception of several patients, to whom the yaginall pessaries incorporating the active hormone were supplied, the hormones
were administered intramuscularly.
single hormone was used.

When it was possible, a

In the majority of patients the hor-

mones were administered daily in doses of 100 rat units for two
weeks with rest intervals of two weeks.

Administration in this

manner was repeated until results justified discontinuation.
If it was possible, the hormones were administered during the
inter-menstrual phase of the cycle.

Sedatives were not dispen-

sed for the relief of subjective symptoms or combined in any
way with these treatments.

The only measures adjuvant to the

endocrinal therapy were the correction of dietetic and hygienic errors.
There was no untoward reactions at the sites of injections.
In a few instances patients received the anterior pituitary
luteinizing hormone complained of slight local pain, 24 to 48
hours after a certain injection, investigation usually revealed
that the injection had been made too superficially.
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Again for the sake of illustration I shall include, in
detail, the cases reported by Hamblen.
Case 1. Mrs J. T., aged 47, para 6-5-1, came to the dispensary oomplaining of nervousness and headaches. During the past
eighteen months her menstrual periods had gradually grown more
scanty and more irregular. For the past 6 months she had experienced marked. vasomotor instability, characterized by fainting spells, flashes, and emotional insta.bili ty., General physical examination revealed nothing of particular importance.
Pelvic examination showed no pelvic abnormalities. She was
given theelin, 100 rat units daily for two weeks, she noticed
at the end of this treatment a disappearance of the emotional
and nervous symptoms after two weeks rest, she reported a menstrual period, which persisted and lasted for a week. She was
given another two weeks treatment with theelin and the relief
of the presenting symptoms continued. She had continued, however, to have a scant sanguinous discharge and, accordingly,
was admitted to the hospital for a curretage of the uterus.
The curettings were reported to show hyperplastic endometritis.
Bleeding has not recurred since the operation and after two
weeks or rest another series of theelin injections will be given.
Case 2. Mrs W. S. Mc., aged 53 was seen in the dispensary
to which she came with the symptoms of flashes, nervousness,
and vertigo since the climacteric two years previously. She
also complained of a low grade lumbar backache of an inconstant
character. Physical examination and pelvic examination were
essentially negative. The patient was slightly underweight.
Laboratory findings we.re vii thin the range of normal. She was
given theelin, 100 rat units daily for two"'weeks and then three
times weekly for four weeks. After a week of treatment the
patient was free of subjective symptoms. There was no return
of menstruation.
Case 3. Irs G.G., aged 46, para 6-0-6 had had scanty and
irregular menstruation for the past year. The ss~ptoms which
brought her to the gynecological clinic were extreme nervousness, loss of appetite, gaseous eructations, and an inconstant
lumbar backache. Physical examination disclosed no important
abnormalities. The patient was slightly underweight. Pelvic
examination revealed no pelvic disease. Laboratory findings
were normal. She has been under treatment for the past 6 months, during which time she has received theelin, 100 rat units
three. times a week for two weeks with rest intervals of two
weeks. She has reoeived relief from her symptoms, except the
backache. The menstruation has become more regular b~t still
remains scanty.
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Case 4. Miss L.G., aged 47, was referred tp our clinic
for diagnosis and treatment. She had had no menstruation for
17 years. Her complaints were very varied, and included marked
emotional instability, extreme nervousness, menifested by gross
tremors, and many indefinite and inconstant pains. A diagnosis
of involutional psychosis was made by the neurological consultant. Her physical examination revealed nothing of consequence
except marked vasomotor inata..bili ty, gross tremors of extremities and exaggerated reflexes. The wassermann test was negative.
A trial of theelin was made. She was given 100 rat ~nits three
times a week for eight weeks without any improvement or without
any relief of symptoms. There was no return of menstruation.
Case 5. Mrs A. I., aged 46 was referred to the clinic with
symptoms of morning parietal headaches, flashes, emotional and
vasomotor instability and marked melancholia. These symptoms
had appeared during the last year and had been much intensified
following the cessation of menstruation seven months previously.
Physical examination revealed nothing of importance except a
coarse tremor, refractive error of the eyes, well corrected
with glasses, and a moderate obesity. Laboratory examinations
were unimportant; She received theelin, 100 rat'units, daily
for three weeks with rest intervals of one week for three months.
The subjective symptoms, except occasional slight headaches,
were, relieved after the first two weeks of treatment. There
has been no return of menstruation.
Case 6. Mrs B. S.t aged 40, para 2';'2;;;'5, was admitted to
the hospital, complaining of an almost constant frontal headache of approximately 6 months duration. During this time there
had been a marked decrease in menstrual flow, associated with
extreme nervousness, flashes, emotional instability and increased
severity of the headaches. Blood pressure at time of admission
was 210/160. Urinanalysis gave normal findings. Blood urea
was 66 mgm. per 100 cc. Physical examination revealed a moderate
enlargement of the heart with good regularity and no murmurs;
eyes and sinuses were normal. Radiography of the sella turcica revealed a slight hypoplasia. She was given a 1/4 grain
hypodermic injection of morphine at the time of admission for
the immediate relief of an almost unbearable headache. Subsequent treatment consisted of a diet of moderately restricted
protein and the administration of anterior pituitary luteinizing hormone 200 rat units daily for ten days. During this time
the patient was confined to bed in the hospital. After two
days of this treatment, the headache disappeared and during
the last two days of the treatment there occured the first free
and normal menstrual cycle the patient had had in six months,
without the usual symptoms and with no headache. At the time
of discharge from the hospital her blood pressure was 150/96
and blood urea was 38 mgm. per 100 cc. She. is to receive further
treatment.

34

Case 7. I. R., aged 24, para 0-0-0, was referred to the
dispensary for treatment of symptoms fcllowing a hysterectomy and
bilatera~ salpingo-oophcrectomy in another hospital in July, 1930.
The patient complained of lcss cf apetite and weight, insomnia, failure
to regain stre:ugth, and nervousness. Physical examination and labcratory tests revealed no abnormalities. She was given theelin, 100 rat
units daily for two weeks. She reported at the end of the treatment
a eomplete relief of subjectiTe symptoms. She recently returned to the
clinic after a month's rest from treatment and during this interval,
had had no return of symptoms.
Case 8. Mrs. J. G., aged 30, para 4-4-0, complained of nervousness,
insomnia, flashes, and frequent attacks of vertigo. Her operative
history included an operation elsewhere in 1927, at which time a left
oophorectomy and right partial oophorectomy were done. She had received
radiua therapy elsewhere in 1928 • th resulting cessation of menstruation. llier symptoms dated from that time. General examination and
laboratory findings were unimportant, except for marked emotional and
vasomotor instability. She received theelin, 100 rat units daily for
two weeks. There was a reduction in the severity otthe symptoms and
at the end of the treatment, there was a noticeable impro_ement of
vasomotcr balance. She was unable to continue further treatment.
Case 9. E. B., aged 29, was referred to the gynecological clinic
for treatment. She had had a bilateral salpingo-oophorectomy in 1919.
During the past two years, she had experiences flashes, vasomotor
instability, characterized by nervousness, frequent sweats, and weakness, and inconstant and ill-defined headaches. Physical examination
and laboratory tests disclosed no important findings. She was given
theelin, 100 rat units daily, for two weeks with relief of symptoms
and disappearance of 'Vasomotor instability. At the end of two weeks,
with rest from the treatment, she reports no return of symptoms.
Case 10. Mrs. I.K.H., aged 44, was referred to the clinic for
treatment. She complained of melancholia, emotional instability,
flashes, and nervous instability. These symptoms dated from radium
therapy elsewhere three years previous which resulted in the cessation
of menstruation. General examination disclosed only moderate obesity.
Laboratory findings were of no importance. She was given theelin, 100
rat units daily, for three weeks. During the latter part of this
treatment, she began to complain of pelvic cramps, associated with a
sensation of fullness in this region and discontinued treatments in
fear that menstruation was returning. She received an almost eomplete
relief of subjective symptoms; menstruation did not result from her
treatments.
Case 11. Mrs. R. L., aged 45, para 6-0-6, complained of general
malais:, dizzy spells and numbness in .the left flank, following an
operatlon in August, 1930, whioh involved bilateral salpingo-oophorectomy and supravaginal hysterectomy. General examination, pelvic
examination, and laboratory studies gave normal findings. She was
given vaginal pessaries, eaoh containing 50 rat units of follicular
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hormone, one to be used each day. She continued this treatment for
six weeks with almost complete relief of her symptoms, except for the
numbness in her left flank.
Case 12. E. H., aged 20, was referred to the gynecological clinic
complaining of weakness', loss of titPeti te, pains in the muscles of the
extremities and loss of weight, following an operation in December,
,1930, which involved bilateral salpingo-oophorectomy. General physical
examination revealid chronic infection of tonsils, malnutrition, and
subnormal we!ght. The patient was of diminutive stature. Laboratory
findings were within the range of normal. She was given theelin, 100
rat units daily, for three weeks. There was an almost complete disappearance of sympt~ms and she has gained five pounds.
The remaining patients treated were those complaining of dysmenorrhea, etc., and do not have a place in this paper.
Hamblen draws these conclusions from the results obtained in
cases of the manopause (natural and artificial).

"Thirteen patients

with symptoms associated with the menopause were treated.

The relief

of subjective symptoms was excellent in eight patients and good in
four.

One patient received no benefit.

There was no effect on men-

struation in ten cases; menorrhagia developed in one patient; and
menstruation became more regular in two patients."
Iazer and Ziserman in their recent work on the female sex hormone,
have come to the conclusion that variations of clinical manifestations
occurring in the climacterium are undoubtedly an expression of the
combined effects produced by different stages of activity on the part
of the glands of internal secretion.

The endocrine pathogenesis, if

it may thus be termed, is of a pluriglandular nature.

The hyper-

sensitivity of the sympathetic nervous system, as evidenced by the
vasomotor symptoms, may reasonably be attributed to the lack of female
sex hormone.

Although the symptoms strongly resemble the syndrome of

hyperthyroidism, there is usually no evidence of an increased basal
exchange.

The administration of female sex hormone in these cases
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is the most rational and clinically the most effective method of
controlling the distressing vasomotor symptoms.
The use of the female sex hormone by mouth has been a question
of much debate.

However, normally, the glands of internal secretion

supply their products to the body as they are needed in small quantities
and without demonstrable disturbances physiologically.

In order to

imitate nature, it is essential to administer glandular products in
small, frequently repeated quantities.

It is apparent that this is

impossible when the products are given by the hypodermic needles.

The

oral administration of glandular products is ideal if the hormone is
not affected by the gastric and intestinal secreti·ons and if it is
pro,perlY absorbed.

The efficacy of the oral administration of female

sex hormone is still debatable.

Large doses given hypodermically are

eliminated rapidly through the urine and other channels before concentration in the uterine mucosa is possible.

Small doses at short

intervals is ideal, but is hard to carry out unless given orally, the
patient usually objecting strenueusly to more than one hypodermic
injection daily.

The administration of the hormone by means of

vaginal pessaries is also unsatisfactory because they can usually be
employed only before retiring.

Furthermore, the gelatin mass almost

invariably escapes from the vagina.
Recent experimentation by Schoeller, Dohrn and Rohlweg tends to
show that the peroral effect of follicular hormone preparations
depends not only on the dose administered, but also on the presence
of certain concomitant SUbstances which further the adsorption of
the hormone.

Using favorable concomitant substances (alcohol in

.".,..-.

various strengths) in suitable amounts, it was found that the relationship between the effective subcutaneous and peroral doses was 1:4
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approximately.
Bowman and Bender have recently studied the effect of female
sex hormone in cases of involutional psychosis.
Severe cases of involutional melancholia were treated with
ovarian hormone in the form of Squibb's amniotin.
amount of treatment varied.

The method and

A careful study before and after treat-

ment was made of the blood pressure, basal metabolism, blood chemistry,
and the galactose tolerance.
Two cases showed a good social recovery.
unimproved and now show a chronic picture.

Three cases were

Two cases died - one

of anemia and broncho-pneumonia, and the other of carci. . .a of the
uterus.
In giving amniotin, the possible restoration of the menstl:ua.l
cycle was considered.

The results were quite different.

Except in

case 1, where a very slight flow occurred on two occasions, the effect
of treatment was to cause complete cessation of the menses.

In three

cases, there was menstruation up to the time of treatment, but none
after treatment started.

In case 2, menstruation continued for two

months after treatment and then ceased.

Case 6 had had a pan-hyster-

ectomy so that no changes were possible.

Case 7 had had the menopause

eleven years previously and treatment produced no effect.
Very little change occurred in the blood chemistry during
treatment.

Where such changes did occur, they

direction of a more nonnal condition.

we~e

usually in the

However, some cases did show

disturbances in weight, arterial tension, an increase in non-prGltein
nitrogen not due to any apparent cardia-renal-vascular disease, a low
blood cholesterol, disturbances in sugar curves, and low basal meta-
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boll sm.

These may all be .avorably influenced by glandular therapy,

especially the specific female sex hormone.

Such therapeutic measures

may improve the patient's general physical eondition, alleviate
distressing symptoms, remove abnormal sensations which may be feeding
delusional trends, shorten remissions, and in some instances are
apparently associated with complete clinical recoveries.
An intelligent application of such therapeutic measures specifically directed against known symptoms and laboratory findings, may
offer a valuable means of treating properly selected cases.

Patients

who show depression, indecision, delusional trends directed agaim t
the environment, and without visceral disturbances and their associated
hypochondriacal trends, will probably not be benefited by such
treatment.
~.

Re-establisbment of menses should not be the aim.

On the

other hand, it may be possible to hasten a complete cessation of
menses where the disturbance includes an annoying continuance of
seanty, irregular menses or metrorrhagia of the menopause not due
to uterine pathology.

The combination of the sex hormone, especially

wi th thyroid in cases of low metaboli sm, and wi th "];)i tui tary , obviously
suggests itself.
Iovak in a recent article is very enthusiastic over the recent
advances made in endocrine therapy •. He states, "Kot so many years
ago, the subject of endocrinology would have had to be approached
almost apologetically, for the profession had, to use a slang
expression, become ffed up' on the immense amount of misinformation
and speculation emanating from the early enthusiasts on the subject.
Such a cynical attitude is no longer justified, and indeed, is no
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longer evident.

The reason for this is obvious.

Io longer is

endocrinology a happy hunting ground for clinicians armed only with
high-powered imaginations, or for oommercial pseudo-soientists with
something to sell.

The field is now being painstakingly worked by an

army of scientific investigators."
Novak points out that the older commeroial preparations of the
ovary or corpus luteum, formerly so widely used, produce no objeotive
results whatever, and that their
able.

subjecti~~

effects are very question-

Some observers have reported favorable results but the psychic

factor associated with the menopause must be born in mind.
Novak calls attention to the faot that theelin has no direct
effect upon the ovary, its use being purely substitutional.

Theelin

can not produce the complete menstrual oycle; its use .hould be
followed by progestin, but as yet no commercial preparation of
progestin is available.

Novak has used, however, the anterior

pituitary luteinizing supstance prepared especially by Park, Davis,
and Company, following injections of theelin, with a fair degree of
success.
time.

This sUbstanoe is not available, however, at the present

Theelin followed by the above preparation will produce menstru-

ation, but not at regular intervals, and requires monthly injeotions
which are objected to rather strenuously by the patient.
Marked improvement in cases of menopausal symptoms has been
reported by ][ovak using theelin in doses of 50 to 100 rat units daily
for at least six days.

4.0

Geist and Suielman have also carried out experiments using
.,I;

amniotin as a therapeutic measure in the menopause.
Amniotin (Squibb) is prepared from the fetal fluid of
cattle by precipitation with alcohol, acetone, and ethyl ether.
The resultant oil is further extracted with alcohol and benzine and the resultant filtrate contains the amniotin which
can be dissolved in water.
to the technic of Doisy.

The assay is carried out according
The rats after the injection of the

material must show fully cornified vaginal smears.
This series consisted of 43 cases.

In 10 there was no

improvement, in 22 cases there was varying improvement, and
in 11 eases the improvement was related to the appearance of
vaginal bleeding after treatment.
Amniotin was given in suppository form and by subcutaneeus
or deep injections.

The result was summarized as follows:

In one group of cases amniotin seems to have influenced
a return of the menstrual period with a temporary relief of
symptoms; in other cases it caused a distinct alleviation of
symptoms while the substance was exhibited, but the relief
was not of a permanent nature.

What influence the psychic

effect of the treatment played is hard to evaluate.

However,

it is evident that the substitution of a single honnone that
is not being produced by the individual, is not sufficient to
prevent entirely the symptoms of the menopause, and it is certain that other factors are included in the problem of the
menopause and its associated symptoms.
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Clinical studies of supposed hypofunction of the ovaries
are seriously handicapped by the lack of an objective and mathematical index of ovarian activity.

The situation is analo-

gous to the observations made on hypothyroid syndromes before
basal metabolic rates wer"e measured.

But both clinical and

fundamental scientific profit accrued from the more or less
empirical association of certain symptoms with deficiency of
thyroid secretion.

It must not be forgotten that even tech-

nical1y perfect basal metabolic measurements sllowing low rates
do not in every case demonstrate' a hypothyroidism.
observation is just as necessary as before.

Clinical

The status of ob-

servations on the menopause and other menstrual irregularities
id one of rather imperical grouptng based on the history and
physical findings.

Lacking specific tests for ovarian activity

in the human female, the clinician must make diagnoses that
are probable rather than certain.

The closest approach to a

specific test for the female sex hormone has been previously
discussed.
Severinghaus and Evans have also used amniotin in the
treatment of menopausal symptoms and report the following results:
·------------------~H~·&o-ee~f-eO~~~s~e~sr-~E~e~n~e~f~iHt~e~dr-~~~omu~~rrottfrrrai~--~N~o_re1ief

Group
1. Menopause, with
flushes and insomnia.
2. Headaches with
suspected menopause.
3. Involutional
psychosis.
Totals

. 15

10

3

2

1

1

3

:3

21

4:

12

1

8
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It appears that in this series of cases amniotin possesses
the activity for the human female which the animal experiments
'of Allen and Doisy would lead us to predict.

In the hot flushes,

insomnia, nervous instability, and headaches attributable to
the menopause, artificial or spontaneous, amniotin has given
very satisfactory relief.
The manufacturers of this preparation (E.R. Squtbb and son)
as well as others, have recommended the use of much larger
doses than were employed.

For the menopausal symptoms, doses

of about 10 units daily are adequate, and may occasionally be
excessive.

Pessaries give results equally as good as hypoder-

mic injections.

The occasion for the use of pessaries is the

avoidance of the need of a hYPodermic.
ties to be encountered however.
are apt to abject to this method.

There are two difficul-

One is that unmarried women
The other is that except with

very firm closure of the vaginal sphincter there is sufficient
drainage after the melting of the gelatin to occasion discomfort and loss of material.

This is preventable by the use of

wool or cotton vaginal tampons.
In 1864 Frankenhauser described a nerve supply of the uterus,
and located a sympathetic nerve plexus lateral to and on each
side of the cervix uteri in the transverse parametnium.

At

puberty. certain hypertrophic changes occur in these two large
ganglia and regression changes likewise occur at the menopause
independent of other sympathetic nerve ganglia.

If we remove

the uterus by a sub-total hysterectomy and leave the ovaries

43

the patient may, for a year or so, have no untoward symptoms,
but later organized exudate and granulation tissue cause atrophy chaBgesin the cervical ganglia, and ovarian deficiency is
then evident.

Experiments conducted by Kennedy show that

regenerative changes occur in these ganglia after castration
or menopause on the administration of sistomensin, which is
a solutioh of oestrin in oil.

According to Kearns climacteric

neurosis improves greatly on the injection of sistomensin.
The explanation of the biological behavior is expressed
by regenerative changes in the mucosa of the uterus and also
by

checking immature developement in the corpus luteum.

Sisto-

mensin will also supply the .corpus luteum hormone when it is
decreased in the menopause.
Present day treatment with the female sex hormone has been
dealt with very thoroughly by Emmert of st Louis.

According to

him, if we sift the enormous and often conflicting literature
on the female sex hormone we find only a few outstanding facts
which seem to be definitely established.

We know that the ovary

remains in the dormant state from birth until the approach of
puberty, and that during this first epoch in the life of the
female it does not as yet produce any hormone in appreciable
amounts.
In contradistinction to the sex gland the other endocrine
glands are active from the very beginning among these, the pituitary gland, which is composed of two lobes, secretes different
hormones in each lobe.

It is the hormone produced in the anterior
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lobe of the pituitary gland which has a fundamental influence
upon the sex organs because it stimulates the ovary both as to
growth and function.

Under the influence of the anterior part

of the hypophysis the follicles of the ovary ripen and secrete
a hormone, which in turn causes a growth and proliferation of
the endometrium in the uterus.

After the rupture of the follicle

there is established in the latter the corpus luteum which
also produces a hormone that in its action is similiar to the'
hormone contained in the follicle.
We must, therefore bear in mind that the anterior lobe
of pituitary is a sort of super-sex gland.

Without the pitui-

tary gland there is no activity of the ovary, and without the

-

ovary there is no activity of the uterus.
Subnormal activity or hypofunction of the ovary is characterized by the absence or scantiness of menstruation, frequently accompanied by obesity and sterility.

The exact class-

ification and grouping of these cases is extremely difficult.
still more unsatisfactory is the present state of treatment.
For many years therapy for all functional disorders consisted
of the oral administration of the whole ovary or certain parts
of it.

Then it was realized that in any dried product there

could be only a minute quantity of actual hormone, and this
tiny amount was sure to be effectively destroyed by the gastric
juice long before it could possibly be absorbed into the organism.

Then extracts for intramuscular use appeaned on the mar-

ket, little more success was had with them.

Claims made by
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endocrine enthusiasts always stirred up hope, but the same results could not be produced in the hands of other men, and when
men like Allen and Doisy, Frank, Graves and others clearly demonstrated that the commercial preparations contained only small
amounts of hormones, it was realized that with our endocrine
enthusiasts the wish had largely been father to the thought.
Since that time the hormone has been definitely standardized and has also been obtained in pure form.

Hand in hand

with this goes the isolation of the anterior pituitary hormone.
These two discoveries mark a new milestone in the developement of

organotherap~.

From now on we shall be in a position

to work with accurate amounts of a definitely determined substance.

The anterior pituitary hormone shall be used to stim-

ulate the ovaries and while we are waiting for the ovaries to
respond to the stimulus of the pituitary we shall inject the
ovarian hormone so that the uterus !ray not be peprived of the
essential need of the ovarian secretion.

In other words in ovar-

ian hypofunction we shall carry out- a stimulation and a substitution therapy simultaneously.

Where, however, there is no

ovarian tissue left, as after castration, or where it is definitely atrophied, as after menopause, there is obviously no need
for pituitary hormone and only ovarian hormone is required
tOo substitute for lack of secretion from the sex gland.
Collip in his work on the human placenta found that it
contained at least three distinct active principles, or hormones.

These three substances were alike in that all have

been observed to be oestrogenic in the immature female rat.
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The first fraction was identified to be theelin.

The active

principle present in the second fraction (85 per cent alcohol
solublej is very similar to theelin in its ultimate p
logical effects.

sio-

It is ineffective, however, in the

and hence it may be concluded that it functions direc
indirectly by stimulation of the intact ovary.

It al

ers from theelin in the degree to which it is effecti
oral administration.

The third fraction prepared fro

the

alcohol insoluble material of the origional extract i
to the other two in that it is oest-rogenic.

It diffe s from

the second or emmenin fraction on three main points:
is ineffective by the oral

~oute;

similar

1) it

(2) it produces

ora

lutea in the immature rat coincident with induced

rus;
acc-

(3) it causes an increase in the rate of
essory sex glands in the immature male.

theelin

The two oestrogenic placental hormones

which have been described appear to be the counterpar s respectively in placenta of prolan A (oestrogenic) and polan B
(oestrogenic and , luteinizing).
Collip treated 18 cases of the menopausal syndro e with
emmenin, ,in 14 there was definite improvement.
improvement in castrates.

There

Collip states; "Observatio

type of case lead one to conclude that the duration

0

5

of this
this

symptom complex is of prime importance, since no reli
obtained in cases of long standing, whereas the symptoms were
releived. for a time at least in certain cases where the con-
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dition was of recent origin - that is, less than one year
since the last menstrual flow.

II

A dose corresponding to 75 grams of placenta daily, given
in divided doses in water or orange juice before meals, has
been used in the majority of cases.
who do not tolerate the extract well.

There are individuals
The cause of this could

not be discovered; but j.n any case in which untoward symptoms,
such as nausea or vertigo, have been observed, the dose was
temporarily reduced until tolerance was acquired.
It was also found that during the course of treatment with
the ovary stimulating hormone of the placenta certain patients
have manifested symptoms of nausea, whilst others experienced
some discomfort in the pelvic region.
had experienced dreams of a

vi~id

Others stated that they

and unusual character.

headache and mental depression have also occured.

Severe

As a rule

the patients voluntarily expressed a feeling of well-being in
from four to five days after withdrawal of the extract.

It is

interesting to note that in view of the well established fact
that the extract 1-s without effect on the oophorectomized: rodent, clinically one cannot expect relief from menopausal symptoms after pan-hysterectomy.

One such case was studied, with

the anticipated failure to obtain any beneficial results.
Collip has definitely established thru extensive experimentation that the active principle obtained from the placenta
"emmenin" i.s an

ova~y

stimulating hormone, probably pi tui tary

in nature, and may be found effective in the activation of
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ovaries which are hypofunctional.

Collip also discovered that

the hormone is non-protein in character and is unaffected by
digestive enzymes.

It may therefore be administered orally.

Now let us consider the secretion of the corpus luteum,
and its possible relation to the menopause.
In corners origional experiments on the corpus luteum he
discovered that the alcoholic extracts of the corpus luteum,
freed from phospholipids, contain a substance which when injected into castrated adult female rabbits induces a characteristic alteration of the endometrium identical with the progestational proliferation previously ,shown to be due to the
presence of corpora lutea in the ovaries.

A similiar effect

is sometimes but not always produced in immature rabbits 8 to
12 weeks old.

Extracts of follicular fluid containing large

amounts of theelin do not produce progestational proliferation,
nor have extracts of human placenta given positive results.

It

appears, therefore, that the extracts of corpus luteum contain
a special hormone which has for one of its functions the preparation of the uterus for reception of embryos by inducing
progestational proliferation of the endometrium.
In the human menstrual cycle the progestin secreted by the
active corpus luteum following ovulation normally prevents
further ovulation and brings about the characteristic premenstrual, secretory changes inthe endometrium, the ovarian
follicle hormone, theelin bei.ng a necessary factor in this
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process.

The d.ecrease in progestin toward the end of the cycle

is followed by menstruation.

To account for the rise and ca-

dence of the corpus luteum and the concomitant variations in
progestin it is necessary, for the present to postulate that
when the graafian follicle reaches a certain stage in its
growth under the influence of the gonad - stimulating hormone
of the anterior hypophysis there takes place increased hypophyseal activity, with consezuent ovulation and luteinization.
From the foregoing explanation it is evident that progestin prevents menstruation, or in other words is antagonistic to the action of theelin, consequently, progestin would
be indicated in cases of excessive flow, rather than cases of
ammenorrhea, that are encountered in the menopause.

Since

however there is no commercial preparation of progestin available at the present time it is impossible to proove this point
clinically.

It has been prooven experimentally however that

the hormone progestin inhibits the production of theelin and
promotes its excretion.
Glismann in studying cases of excessive hemorrhage, recommends the use of lipo-lutin, a potent lipoidal extract of
corpus luteum, which is prepared by Parke, Davis and Company.
This product has been found to be very useful in preventing
abortion and excessive menstrual flow due to endocrine imbalance, however it has been used in cases of post menopausal
bleeding with an equal degree of success.

The reason for this
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is readily seen, bearing the foregoing discussion in mind.
Geist and Matus in a recent study of post-menopausal
bleeding have found the cause to be chiefly benign and malignant tumors, however tbey call attention to the importance
of a study of the circulating blood and the tumor for the
presence of hormones that may lead to a clearer understanding
of the mechanism of the bleeding.
We shall now consider the pituitary hormones as to their
-possible therapeutic value in relation to the menopause.
- N~1:,son in -recent experimentation observed 8 rats out of
several hundred, that exhibited no oestrous change for at
least five weeks.

These animals were apparently in the best

of health and quite normal in every respect except for their
reproductive cycles.

Age, inanition, and vitamin B deficiency

could be ruled out. as causative factors, since the history
of each animal was known.

The possibility suggested itself

that some factor in the normal pituitary gonadal relationship
was inactive in these animals.
After a period of anoestrous lasting from five to seven
weeks one ovary and a portion of the uterus were removed in
each instance.

All material was fixed in Bouins and prepared

for histological study.

Two weeks was allowed for recovery.

No oestrous changes occurred in any case.

Seven of the animals

were injected intramuscularly with one fresh anterior lobe
(rat) each day.

The 8th animal was given subcutaneous inject-

ions of an extract prepared from sheep pituitary.
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In every instance oestrus occured on the third or fourth
day following the instigation of treatment.

The smear of

flaky, cornified cells was typical in every respect of a normal
oestrus and was preceded by the usual pro-oestrous picture.
Subsequent autopsy revealed' the typical condition of oestrus.
The rapid response of these non-cyclic females to anterior
pituitary therapy seems t9 justify the initial supposition
that some factor in their pituitary-gonadal relationship was
inactive.

We are reasonably certain at the present time, that,

of the entire endocrine series the anterior hYPophysis is the
only gland which is fundamentally concerned with the normal
functioning of the gonads.

In all probability other glands,

notably the thyroid, have their roles in the maintenance of
gonadal function, and disturbances in them may well be reflected in the gonads.

However, all recent work has served to re-

legate them to a position of minor importance and has elevated
the hypophysis to the major role.
Nelson summarizes his work as follows:
1. Eight adult female rats, which for at least five

weeks had shown no oestrous changes in their vaginal smears,
were given daily implants of anterior lobe, or daily injections
of an extract prepared from anterior lobe material.
2. Oestrous occured, in each instance, on the second

or third day subsequent to the instigation of treatment.
3. The ovaries and uteri prior to treatment presented

a picture approximating that of dioestrus, while the remaining
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ovaries and uteri removed subsequent to the occurrence to the
induced oestrus were either of oestrous or meta-oestrus character.
4. When copulation was permitted at the time of induced
oestrussllccessful pregnancies resulted.
'/

5. The pituitaries of these females were c;:tpable of promoting precocious maturity in a young rat when introduced intramuscularly.
6. No further oestrus changes could be demonstrated
beyond the initial induced oestrus.
7. It is eonclu4ed that the etiology of the aberrant
ovarian behavior observed in these animals probably was some
derangement of the normal hypophyseal-gonadal relationship,
possibly the non-release of the gonadal stimulating hormone.
In Hewitts work on extracts of the anterior pituitary, it
was found possible to obtain extracts of anterior lobe of pituitary glands having the following effects.
(1) Growth promoting (filtered al~aline extracts)
(2) Growth promoting and oestrous-inhibiting (unfiltered
alkaline extracts)
. (3) Premature maturity-and ripe follicle producing
(acid extracts treated with kaolin, etc. ).
It would seem therefore that three effects may be produced
by extracts of anterior lobes.

Evidence from histological,

surgical, pathological and bio-chemical fields presents a strong
case for the existence of hormones in the anterior pituitary
lobe controlling growth and the female reproductive cycle.
Two inferences may be drawn: Theoretically one is faced with
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the presumption that the anterior lobe may control the ovarian
cycle, and practically; one may hope for the establishment of
replacement therapy indisturbances of growth and the female
reproductive system.
Evans. Meyer and Simpson in studying the relation of prolan
to the anterior hypophyseal hormones arrived at these conclusions:
1. Prolan does not easily repair the gonadal deficiencies of hypophysectomized animals.
2. There is always a definite limit to the

weiSh~

of

the ovary which can be stimulated by prola,n in the immature
rat within a definite time interval (100 hours).
3. Hypophyseal hormones completely repair the gonadal

-

deficiencies of hypophysectomized animals.
r

4. The hypophyseal gonad-stimulating hormone does not

show the limited effect on the-ovary of the in®ature rat found
to be characteristic of prolan.

The development of the ovary

provoked by the hypophyseal hormone corresponds to the dose
level.
5. Only very small amounts of prolan, measured in terms
of dry weight are required to give the minimal effect on the
ovary.

The amount of hypophyseal hormone needed to give a

minimal effect is always much

greate~.

This is in contrast to

the fact that higher doses of hypophyseal hormone provoke much
greater ovary weights than can be obtained with any amount of
prolan.
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6. In earlier experiments the effect of prolan was increased to the maximal effect obtainable by injecting hypophyseal sex hormone simply by combining prolan with small amounts
of crude hypophyseal preparations, containing both gonad-stimulating and growth hormones.

The combination of prolan was made

with doses of hypophyseal preparations which, given alone,
were minimal or

j~st

sub-minimal in gonad-stimulating effect.

Later prolan was added to the hypophyseal extract (growth hormone) which, whenadministered alone, were devoid of any effect
on the ovaries of immature animals and in this way also secured
maximal effects.
7. This activation effect is a specific reaction.

If

the hypophyseal extract is destroyed by heating, the combination
of heated hypophyseal hormone with prolan is no longer any more
effective than prolan alone.
8. Low concentration of pure hypophyseal sex hormone

combined with prolan do not result in activation effects.

On

the other hand sex free growth hormone is typically activated
by prolan.
Fluhmann published a collective review in 1931 dealing with
the interrelationship of the anterior hypophysis and the ovaries.
The majority of his conclusions have been included in this
paper, however it may be of interest to include his summary of
the use of ovary stimulating substances for therapeutic purposes.
Of special importance to the practitioner is the possibility
arising from experimentation on the anterior pituitary like sub-
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stances, of obtaining an ovary stimulating substance which may
be employed for the treatment of amenorrhea, delayed menses,
scanty menstruation and sterility.

This work must be consider-

ed as still in the experimental stage but it is of interest that
investigation along this line is proceeding hand in hand with
the physiologic studies.

The extracts at present in use thera-

peuticallyare either made from the urine of pregnant women,
as for example, prolan, or from the placenta, as emmenin.
Encouraging results in the treatment of so-called "hypoovarian" conditions from the use of the German preparations
prolan, pre-hormone and homhormone, have been reported by Zondek,
and others.

Zamkoff has also had very encouraging experiences

from the use of urine from pregnant women, and good results
from the injection of whole blood or blood serum from human
pregnant donors have been reported by de-l./faortua and Esch.
Zondek has employed prolan for the treatment of pelvic inflammatory disease in view of his previous observation that the administration of this extract causes a local increase of temperature, and believes that in association with bed-rest this method
of therapy is highly commendable.

This contention is support-

ed.by Montag, but on the other hand an adverse report has been
given by Bauer and Lehfeldt, who in addition failed to obtain
successful results in 10 cases of menstrual distuvbances attributed to ovarian dysfunction.

Fellner beiieves that feminin

is preferable to anterior pituitary hormone from a therapeutic
standpoint in view of the danger of injury to the ovaries.
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Martin has successfully used prolan i~ high dos~s for patients
with intractable menorrhagia, and suggests this as a possible
means of producing a hormonal castration.
The treatment of 135 cases of deranged ovarian function
by the oral administration of the placental extract emmenin has
been reported by Campbell and Collip.

These authors note un-

satisfactory results in the treatment of primary amenorrhea,
but find a high percentage of patients with improvement in cases
of 2ndary amenorrhea, oligomenorrhea, dysmenorrhea, polymenorrhea, and menopausal symptoms.

They have also obtained an areest

of the bleeding in certain forms of menorrhagia and metorrhagia
by the hypodermis administration of Collips "anterior-pituitarylike" placental extract.
CONCLUSIONS
1. Tne menopause is a normal physiological process thru

which all women must pass.

The symptoms may be very severe

in some cases while in others it may be as uneventful as any
of the other necessary experiences to which the female economy
is subj ected.
2. The average age of cessation of menses is apprOXimately
45 years 9 months.

The average duration of symptoms is about

two to two and a half years.
3. All organs of the female reproductive system are supjected to atrophic changes during and following the menopause.
These changes associated with the usual symptoms are due to
the withdrawal of the female sex hormone.
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4. Drugs are almost always necessary in addition to other
therapeutic measures.

Elixir triple bromides has been found

to be very useful due to its depressing action on the

va~omotor

cen terse
5. The older commercial preparations of whole ovary and
corpus luteum formerly used have little or no potency, and are
quickly destroyed by digestive enzymes.
6. Theelin is of definite therapeutic value in the menopause.

Excessive doses (100-200 R.U. ) may be given without

producing untoward symptoms.

In the artificial menopause the

dose must be large, since no ovarian function is present.

In

milder spontaneous cases the dose need not be so great, since
some ovarian function is still present.
small doses are of definite value.
been unsatisfactory.

In involutional states

The vaginal pessary has

Theelin is of value when administered

orally, when accompanied by favorable concomitant substances.
The ratio of subcutaneous and oral administration is 1:4.
7. In all probabilities progestin is of value in cases of
excessive flow, rather than in cases of amenorrhea.

However it

may be of value in certain cases of post menopausal bleeding.
There is no satisfactory commercial preparation of progestin
at the present time.
8. The anterior pituitary hormone is of value in some cases
of menopausal symptoms.

It is evident that pituitary would be

of no value in the artificial menopause.

In cases where some

active ovarian tissue remains it would be indicated.

The

COIDm-
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ercial preparation antuitrin-S has not been in use long enough
to draw any definite oonolusions.
9. The symptom oomplex of the menopause is not due to a

deorease or absenoe of only one hormone, the entire endoorine system is involved.

Consequently perfect results oannot be ob-

tained by substituting only one hormone.

Properly oonduoted

laboratory procedures as outlined, will give us muoh information
as to the presenoe or absence of oertain hormones, having this
information, the results should be much more enc.ouraging.

How-

ever as yet the laboratory procedures are not perfeoted and the
expense would make the prooedure impraotioal.
the question of oonoentration of extraots.

There is also

At the present time

it is necessary to injeot large amounts of material to get the
desired effect, this amount will eventually be deoreased as it
has been in various serums and antitoxins in use at the present
time.
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